novo nordisk glp-1 Ozempic is first drug FDA-approved for kidney disease Novo Nordisk keeps GLP-1 expansion

Measurable weight loss usually starts during weeks two through four

(With that, its still said to be one of the safest elective surgeries out there.) Other side effects and complications of bariatric surgery include dumping syndrome, where food moves too quickly from your stomach to your bowels, causing symptoms such as cramping, lightheadedness, and diarrhea

Improved sleep quality and reduced recovery time are usually the first signs, followed by visible changes in muscle fullness and the beginning of body fat reduction around weeks 4 through 6

The retatrutide results demonstrated dose-dependent weight loss, with lower doses producing proportionally less but still clinically significant reductions